The Pfizer request to expand emergency use authorization of its COVID-19 vaccine to include children ages 12 to 15 years will be evaluated "as quickly as possible," the FDA says. "While the FDA cannot predict how long our evaluation of the data and information will take, we will review the request as expeditiously as possible using our thorough and science-based approach," FDA Acting Commissioner Janet Woodcock said on Twitter, CNN reported.